Icon

NUCYNTA ER (nda200533)- (EQ 50MG BASE,EQ 100MG BASE,EQ 150MG BASE,EQ 200MG BASE,EQ 250MG BASE)

TAPENTADOL HYDROCHLORIDE COLLEGIUM PHARM INC
EQ 50MG BASE,EQ 100MG BASE,EQ 150MG BASE,EQ 200MG BASE,EQ 250MG BASE
Yes No
2028-Sep-22 2013-Nov-20
None None
None No
NUCYNTA ER is an opioid agonist indicated for the management of: • pain severe enough to require daily, around-the-clock, long-term opioid treatment and for which alternative treatment options are inadequate • neuropathic pain associated with diabetic peripheral neuropathy (DPN) in adults severe enough to require daily, around-the-clock, long-term opioid treatment and for which alternative treatment options are inadequate.
0 3 0
Total Other Developers 1
Drugs with Suitability No
EQ 50MG BASE ** ** Up - -
EQ 100MG BASE ** ** Up - -
EQ 150MG BASE ** ** Up - -
EQ 200MG BASE ** ** Up - -
EQ 250MG BASE ** ** Up - -
NDA Sales Available Total Generic Sales Available
Yes 0
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search





Expired
to
Expired
to


Please contact contact@researchdelta.com to get more details.